Addus HomeCare (NASDAQ:ADUS) EVP Brian Poff Sells 820 Shares

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Brian Poff sold 820 shares of the business’s stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total value of $86,395.20. Following the completion of the sale, the executive vice president directly owned 63,692 shares of the company’s stock, valued at $6,710,589.12. This represents a 1.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Brian Poff also recently made the following trade(s):

• On Tuesday, February 24th, Brian Poff sold 2,041 shares of Addus HomeCare stock. The shares were sold at an average price of $106.98, for a total value of $218,346.18.

Addus HomeCare Stock Performance

ADUS traded down $3.58 on Thursday, hitting $104.02. The company had a trading volume of 269,378 shares, compared to its average volume of 239,147. The stock has a market cap of $1.92 billion, a price-to-earnings ratio of 19.97, a price-to-earnings-growth ratio of 1.26 and a beta of 0.91. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.80 and a quick ratio of 1.66. The company’s fifty day moving average price is $109.57 and its 200 day moving average price is $113.08. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $124.43.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on ADUS shares. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, January 21st. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday. Barclays lowered their price target on Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday. BMO Capital Markets initiated coverage on Addus HomeCare in a research note on Thursday, November 13th. They set a “market perform” rating and a $120.00 target price for the company. Finally, Stephens dropped their price target on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $134.33.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Royal Bank of Canada lifted its position in Addus HomeCare by 24.3% during the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock worth $682,000 after buying an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Addus HomeCare by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock valued at $1,026,000 after buying an additional 459 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Addus HomeCare by 6.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after buying an additional 2,952 shares during the last quarter. Jane Street Group LLC grew its position in shares of Addus HomeCare by 387.6% during the 1st quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after buying an additional 8,780 shares during the period. Finally, Intech Investment Management LLC grew its holdings in Addus HomeCare by 44.7% during the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock valued at $1,420,000 after purchasing an additional 4,439 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Key Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&A-driven growth strategy for 2026 — supports longer‑term earnings upside. Addus HomeCare Earnings Call Highlights Growth And Scale
• Positive Sentiment: Stephens trimmed its price target from $140 to $135 but kept an “overweight” rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. Stephens price target note
• Neutral Sentiment: Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). Conference participation
• Neutral Sentiment: Some published short‑interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. MarketBeat ADUS page
• Negative Sentiment: Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre‑planned. See CEO filing. CEO insider-sale SEC filing
• Negative Sentiment: Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days‑to‑cover) — elevated short activity can amplify downward price moves. Short interest data

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.